Type 1 Diabetes Trial, Recruiting NCT06686329 Sponsor: Jane Yardley Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06686329
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 24 years old
  • You have been diagnosed with Type 1 diabetes for at least two years
  • Your recent blood sugar control level (measured over the past 30 days using a continuous glucose monitor) is below 9.9%
  • You already use a Dexcom G7 continuous glucose monitor (CGM) as part of your regular care

Who may not be able to join:

  • Your insulin treatment plan has changed in the last 2 months
  • You have been diagnosed with gastroparesis (a condition affecting how the stomach empties food)
  • You have a health condition that could make exercise unsafe for you
  • You are intolerant to gluten or lactose
  • You have significant kidney disease (confirm with trial site)
  • You are unable to give informed consent due to a cognitive impairment
  • You are currently taking medications other than insulin that can affect blood sugar levels — unless the dose has been stable for more than three months (confirm with trial site)
  • You are currently pregnant or breastfeeding (applies to women)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 514-987-5597

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jane Yardley
Registry
ClinicalTrials.gov
Start date
17 March 2025
Est. completion
30 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Mean glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov